PTGX
NASDAQ · Biotechnology
Protagonist Therapeutics Inc
$100.39
+1.85 (+1.88%)
Performance
1D
—
1W
—
1M
—
3M
+13.08%
6M
+48.90%
1Y
+96.65%
YTD
+15.15%
Open$97.16
Previous Close$98.54
Day High$100.98
Day Low$97.16
52W High$105.69
52W Low$39.60
Volume—
Avg Volume998.7K
Market Cap6.31B
P/E Ratio—
EPS$-2.04
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$85.10
Above
SMA 200
$67.75
Above
RSI (14)
58.3
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
19 analysts
Price Target
-69.6% upside
Current
$100.39
$100.39
Target
$30.47
$30.47
$24.78
$30.47 avg
$49.57
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 46.18M | 38.46M | 743.95M |
| Net Income | -130,629,200 | -97,914,783 | -91,860,800 |
| Profit Margin | -282.8% | -268.7% | -12.4% |
| EBITDA | -157,403,336 | -124,538,326 | -161,541,358 |
| Free Cash Flow | — | — | -86,698,990 |
| Rev Growth | +20.1% | +20.1% | +6.6% |
| Debt/Equity | — | — | 0.40 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $205.20 | +0.13% | 166.6 | 397.77B |
| AMGN | Amgen Inc | $348.43 | -0.38% | 24.4 | 188.06B |
| GILD | Gilead Sciences Inc | $138.11 | +0.56% | 20.0 | 170.34B |
| VRTX | Vertex Pharmaceuticals Inc | $448.62 | -0.58% | 29.2 | 115.53B |
| REGN | Regeneron Pharmaceuticals | $741.69 | +0.70% | 17.9 | 80.50B |
| ALNY | Alnylam Pharmaceuticals Inc | $308.05 | +0.45% | 139.7 | 43.84B |